Home > Financial Ratios > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EBIT Growth(%) 11.7054.18-2.417.3270.71

What is the latest EBIT Growth ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest EBIT Growth ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 11.70 based on Mar2026 Consolidated results.
Year EBIT Growth
Mar202611.70
Mar202554.18
Mar2024-2.41
Mar20237.32
Mar202270.71

How is EBIT Growth of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2026 11.7
-78.41
Mar2025 54.18
Positive
Mar2024 -2.41
Negative
Mar2023 7.32
-89.65
Mar2022 70.71 -

Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS


Compare EBIT Growth ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹44,687.7 Cr -0.7% 6% 8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹449,228.0 Cr -0.8% 7.3% 7.7% Stock Analytics
DIVIS LABORATORIES ₹293,874.0 Cr -3.3% 21.8% 68.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,413.0 Cr -1.7% 1.9% 22.1% Stock Analytics
DR REDDYS LABORATORIES ₹116,604.0 Cr 0.7% 12.4% 12.4% Stock Analytics
CIPLA ₹114,720.0 Cr 0.7% 6.7% -9.4% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-0.7%

6%

8%

SENSEX

0.2%

9.8%

-2.9%


You may also like the below Video Courses